Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors
- PMID: 2543664
Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors
Abstract
Alternative splicing of fibronectin pre-mRNA at the ED-A region has been shown to be regulated in a tissue- and developmental stage-specific manner. We investigated the splicing pattern at this region in malignant and nonmalignant human liver tissues and found that the relative population of the fibronectin mRNA containing the ED-A sequence is markedly increased in malignant liver tumors. Nontumorous liver tissues including those with chronic hepatitis and cirrhosis did not show any significant change in the alternative splicing at the ED-A region. It was also found that the increased expression of the ED-A-containing fibronectin mRNA closely correlates with the occurrence of portal vein tumor thrombus and intrahepatic metastasis, which are two characteristic features of invasive liver tumors. These results indicate that tissue-specific alternative splicing of fibronectin mRNA is modified in human liver cancer and raise a possibility that the putative molecular machinery governing alternative RNA splicing of not only fibronectin but also other cellular proteins is deregulated in malignant human tumors.
Similar articles
-
Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors.Cancer Res. 1993 May 1;53(9):2005-11. Cancer Res. 1993. PMID: 8481903
-
Patterns of alternative splicing of fibronectin pre-mRNA in human adult and fetal tissues.Biochemistry. 1989 Feb 7;28(3):1428-34. doi: 10.1021/bi00429a072. Biochemistry. 1989. PMID: 2713373
-
Oncodevelopmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues.Cancer Res. 1990 Feb 15;50(4):1075-8. Cancer Res. 1990. PMID: 2297755
-
Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences.World J Gastroenterol. 2010 Jul 7;16(25):3091-102. doi: 10.3748/wjg.v16.i25.3091. World J Gastroenterol. 2010. PMID: 20593494 Free PMC article. Review.
-
Aberrant regulation of alternative pre-mRNA splicing in hepatocellular carcinoma.Crit Rev Eukaryot Gene Expr. 2014;24(2):133-49. doi: 10.1615/critreveukaryotgeneexpr.2014007702. Crit Rev Eukaryot Gene Expr. 2014. PMID: 24940767 Review.
Cited by
-
SUVA: splicing site usage variation analysis from RNA-seq data reveals highly conserved complex splicing biomarkers in liver cancer.RNA Biol. 2021 Oct 15;18(sup1):157-171. doi: 10.1080/15476286.2021.1940037. Epub 2021 Jun 21. RNA Biol. 2021. PMID: 34152934 Free PMC article.
-
Fibronectins in vascular morphogenesis.Angiogenesis. 2009;12(2):165-75. doi: 10.1007/s10456-009-9136-6. Epub 2009 Feb 14. Angiogenesis. 2009. PMID: 19219555 Free PMC article. Review.
-
Fibronectin in Fracture Healing: Biological Mechanisms and Regenerative Avenues.Front Bioeng Biotechnol. 2021 Apr 16;9:663357. doi: 10.3389/fbioe.2021.663357. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 33937219 Free PMC article. Review.
-
Potential mechanism of fibronectin deposits in acute renal failure induced by mercuric chloride.Mol Cell Biochem. 2001 Oct;226(1-2):67-75. doi: 10.1023/a:1012733719017. Mol Cell Biochem. 2001. PMID: 11768240
-
EDA-containing fibronectin increases proliferation of embryonic stem cells.PLoS One. 2013 Nov 14;8(11):e80681. doi: 10.1371/journal.pone.0080681. eCollection 2013. PLoS One. 2013. PMID: 24244705 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical